AWP
TWST icon

Abacus Wealth Partners’s Twist Bioscience TWST Stock Holding History

Abacus Wealth Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
2,236
-3,309
-60% -$215K 0.02% 290
2026
Q1 		$263K Buy
+5,545
New +$249K 0.02% 399

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Abacus Wealth Partners's TWST Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Twist Bioscience (TWST) stake by 60% in Q2 2026, selling an estimated $215K and leaving 2,236 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #290.

Abacus Wealth Partners first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. The position peaked at $263K in Q1 2026. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Abacus Wealth Partners held 2,236 shares of Twist Bioscience worth $230K as of Q2 2026.
  • Abacus Wealth Partners sold 3,309 Twist Bioscience shares in Q2 2026, an estimated $215K.
  • Twist Bioscience made up 0.02% of Abacus Wealth Partners's portfolio in Q2 2026, its #290 holding.
  • Abacus Wealth Partners first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Abacus Wealth Partners's Twist Bioscience position peaked at $263K in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.